RESUMEN
Cornuside is a secoiridoid glucoside isolated from the fruit of Cornus officinalis SIEB. et ZUCC. In this study, we investigated the anti-myocardial ischemia and reperfusion (I/R) injury effects of cornuside in vivo and elucidated the potential mechanism. Rat models of myocardial I/R were induced by coronary occlusion followed by reperfusion or by Isoproterenol (ISO), treatment of rats with cornuside (20 and 40 mg/kg, i.v.) protected the animals from myocardial I/R injury as indicated by a decrease in infarct volume, improvement in hemodynamics and reduction of myocardial damage severity. Treatment with cornuside also attenuated polymorphonuclear leukocytes (PMNs) infiltration, decreased myeloperoxidase (MPO) activity in the heart, lowered serum levels of pro-inflammatory factors and reduced phosphorylated IκB-α and nuclear factor kappa B (NF-κB) levels in the heart. Additionally, cornuside was shown to have remarkable antioxidant activity and inhibited ISO-induced myocardial cell necrosis. Thus, cornuside appeared to protect the rat from myocardial I/R injury by acting as an anti-inflammatory agent. These findings suggested that cornuside may be used therapeutically in the setting of myocardial I/R where inflammation and oxidant injury are prominent.
Asunto(s)
Antiinflamatorios/uso terapéutico , Cornus/química , Glucósidos/uso terapéutico , Infarto del Miocardio/prevención & control , Daño por Reperfusión Miocárdica/tratamiento farmacológico , Fitoterapia , Piranos/uso terapéutico , Animales , Antiinflamatorios/farmacología , Antioxidantes/metabolismo , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/farmacología , Medicamentos Herbarios Chinos/uso terapéutico , Glucósidos/química , Glucósidos/farmacología , Corazón/efectos de los fármacos , Hemodinámica/efectos de los fármacos , Inflamación/metabolismo , Inflamación/prevención & control , Masculino , Infarto del Miocardio/metabolismo , Daño por Reperfusión Miocárdica/metabolismo , Daño por Reperfusión Miocárdica/patología , Miocardio/metabolismo , Miocardio/patología , Plantas Medicinales/química , Piranos/química , Piranos/farmacología , Ratas , Ratas Sprague-DawleyRESUMEN
The embryo spores of Laminaria japonica were cultured in artificial seawater with different N/P ratio to observe their early development. 80 percent of the spores cultivated in whole-ingredient artificial seawater developed normally, but the time of spore germination and gametophyte formation was lagged significantly and the amount of female gametes was significantly higher than that of male gametes (P<0.001), as compared to the control cultivated in natural seawater. Artificial seawater with different N/P ratio showed different effects on the spore germination rate. The artificial seawater with N/P > 15 decreased the spore germination rate, while that without N or P inhibited the spore germination significantly (P<0.001). It was concluded that L. japonica spores could develop normally in artificial seawater, but their germination rate was affected by the seawater N/P. The deficiency of N or P in artificial seawater would lag the time of gametophyte formation and affect the differentiation ratio of female-male gametes.
Asunto(s)
Laminaria/crecimiento & desarrollo , Nitrógeno/farmacología , Fósforo/farmacología , Agua de Mar/química , Esporas/crecimiento & desarrollo , Técnicas de Cultivo , Laminaria/efectos de los fármacos , Esporas/efectos de los fármacos , Esporas/fisiologíaRESUMEN
Effects of scorpion venom active polypeptide (SVAP) from scorpion venom of Buthus Martensii Karsch of Chinese on platelet aggregation in ex vivo and vitro in rabbits, thrombosis in carotid artery of rats and plasma 6-keto-PG F1alpha and TXB2 in rats were studied by the turbidimetry, the duplicated thrombosis model by electrostimulation and RIA, respectively. The results showed that SVAP 0.125, 0.25, 0.5 mg/ml inhibited significantly the rabbit platelet aggregation triggered by 0.3 U/ml thrombin, 10 microM ADP in vitro (P<0.05 or 0.01) and SVAP at the dose of 0.32, 0.64 mg/kg iv prolonged distinctively the occlusion time of thrombosis that were induced by electrical stimulation. Increased% of 0.16, 0.32 and 0.64 mg/kg were 30.16, 71.74, 98.27%, respectively, which showed a good dose-effect relationship. SVAP 0.22 mg/ml (in vitro) or 0.2, 0.4 mg/kg (in ex vivo) could obviously increase the plasma concentration of 6-keto-PG F1alpha, but slightly effect rats plasma concentration of TXB2 in vitro and in ex vivo and significantly increase of value of PG I2/TXA2, which suggested that the mechanism of the antithrombotic action of SVAP is related to the resistance against platelet aggregation, increase of the concentration of PG I2 in plasma.